Cellogen Therapeutics
PrivateLast Round
Strategic
May 18, 2026
Est. Valuation
$33.6M
Total Funding Raised
$4.1M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Cellogen Therapeutics operates in Healthcare & Life Sciences and is based in Noida. Its latest recorded funding round was a Strategic round in May 2026.
Cellogen Therapeutics is a biotechnology company that develops CAR-T cell-based therapies for the treatment of cancer and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cellogen Therapeutics Comparables
Compare Cellogen Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Immuneel Therapeutics | 83% | |
| ImmunoACT | 82% | |
| Caring Cross | 75% |
For institutional investors. Book with your work email.
Cellogen Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | May 18, 2026 | ||||
| Accelerator | Dec 14, 2025 | ||||
| Seed | Jan 17, 2024 |
For institutional investors. Book with your work email.
Cellogen Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kotak Mahindra Trustee | Strategic |
| Kotak Alternate Asset Managers | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors grew 174% MoM, reaching 3.3K.
- Sep 2, 2026
Grew 18% QoQ, from 22 to 26 employees.
For institutional investors. Book with your work email.
Cellogen Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cellogen Therapeutics's valuation, stock price, and market status.
Is Cellogen Therapeutics a public or private company?
Cellogen Therapeutics is a private company.
What is the current stock price of Cellogen Therapeutics?
Cellogen Therapeutics is a private company, so its shares have no public market price. Caplight tracks Cellogen Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cellogen Therapeutics worth (valuation)?
Cellogen Therapeutics's valuation is estimated at $33.6M based on funding round data.
Can I buy Cellogen Therapeutics stock?
Cellogen Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cellogen Therapeutics's last funding round?
Cellogen Therapeutics's most recent funding round was Strategic on May 18, 2026.
Who are the main investors in Cellogen Therapeutics?
Key investors in Cellogen Therapeutics include Kotak Mahindra Trustee, Kotak Alternate Asset Managers.
Will Cellogen Therapeutics IPO soon?
No public IPO plans have been announced for Cellogen Therapeutics.
How can I track Cellogen Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Cellogen Therapeutics's shares on secondary markets.